Latest Breaking News On - Rebecca taub - Page 1 : comparemela.com

Frazier Life Sciences Management L P Invests $16 06 Million in Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL)

Frazier Life Sciences Management L.P. bought a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 69,406 shares of the biopharmaceutical company’s stock, valued at approximately $16,059,000. Frazier Life Sciences […]

United statesPiper sandlerRebecca taubRoberte waltermireSecurities exchange commissionFrazier life sciences managementInsider transactions at madrigal pharmaceuticalsMadrigal pharmaceuticals stock performanceCanaccord genuity groupBain capital life sciences investorsNews ratings for madrigal pharmaceuticals dailyAvoro capital advisorsMadrigal pharmaceuticals incMadrigal pharmaceuticalsQuarter for madrigal pharmaceuticalsFree report

Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL) Receives Average Recommendation of Moderate Buy from Analysts

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have received an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating on the […]

United statesPiper sandlerRebecca taubCanaccord genuity groupAnalyst recommendations for madrigal pharmaceuticalsGlobal retirement partnersMadrigal pharmaceuticals incMadrigal pharmaceuticals stock performanceEntrypoint capitalMadrigal pharmaceuticalsMontaga associates incMadrigal pharmaceuticals company profileNews ratings for madrigal pharmaceuticals dailyGet free reportGenuity groupDirector fred

Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL) Receives $356 73 Consensus PT from Analysts

Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL) Receives $356 73 Consensus PT from Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesJamesm dalyRebecca taubAnalyst recommendations for madrigal pharmaceuticalsProshare advisorsOppenheimer coSecurities exchange commissionNews ratings for madrigal pharmaceuticals dailyRussell investments group ltdMadrigal pharmaceuticalsMadrigal pharmaceuticals incSusquehanna fundamental investmentsMadrigal pharmaceuticals price performanceSwiss national bankGet free reportDirector james

Madrigal Pharmaceuticals (NASDAQ:MDGL) Releases Quarterly Earnings Results, Misses Estimates By $1 32 EPS

Madrigal Pharmaceuticals (NASDAQ:MDGL) Releases Quarterly Earnings Results, Misses Estimates By $1 32 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRebecca taubRichards levyMadrigal pharmaceuticalsMadrigal pharmaceuticals price performanceMadrigal pharmaceuticals company profileEarnings history for madrigal pharmaceuticalsMadrigal pharmaceuticals incSecurities exchange commissionNews ratings for madrigal pharmaceuticals dailyGet free reportDirector richardExchange commissionMadrigal pharmaceuticals daily

Madrigal Pharmaceuticals (NASDAQ:MDGL) Posts Earnings Results, Misses Expectations By $1 32 EPS

Madrigal Pharmaceuticals (NASDAQ:MDGL) Posts Earnings Results, Misses Expectations By $1 32 EPS
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesRebecca taubRichards levyNews ratings for madrigal pharmaceuticals dailyMadrigal pharmaceuticalsEarnings history for madrigal pharmaceuticalsInsider transactions at madrigal pharmaceuticalsMadrigal pharmaceuticals price performanceCanaccord genuity groupMadrigal pharmaceuticals incGet free reportDirector richardGenuity groupMadrigal pharmaceuticals daily